← Back to Catalog
Clinician access
Retatrutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Clinician Only
Metabolic & Foundational
Retatrutide
Retatrutide is a next-generation triple agonist that activates GLP-1, GIP, and glucagon receptors. It supports significant fat loss, metabolic optimization, and appetite regulation.
Available Vials
- Delivery
- Subcutaneous Injection
- Starting Dose
- 0.5mg once weekly
- Titration
- Increase by 0.5–1mg every 2–4 weeks PRN
- Maintenance Range
- 1mg–3mg weekly
- Sourcing
- Compounded in USA
Quantity
Continue Browsing1
More in Metabolic & Foundational
Tirzepatide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Tirzepatide
Subcutaneous Injection
Semaglutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Semaglutide
Subcutaneous Injection
Cagrilintide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Cagrilintide
Subcutaneous Injection
Sign in to view full clinical details
Reconstitution, contraindications, clinic pricing, patient handouts, monitoring cadence, and drug interactions are available to verified clinicians.